Catalpol attenuates cardiomyocyte apoptosis in diabetic cardiomyopathy via Neat1/miR-140-5p/HDAC4 axis

Biochimie. 2019 Oct:165:90-99. doi: 10.1016/j.biochi.2019.05.005. Epub 2019 May 9.

Abstract

The cardioprotection of catalpol and its mechanism in diabetic cardiomyopathy (DCM) remains unclear. Here, mouse cardiomyocytes were treated with high glucose (HG) to establish a model of cellular injury induced by HG. In vitro experiments were carried out and confirmed that Catalpol attenuated HG-induced long noncoding RNA (lncRNA) nuclear paraspeckle assembly transcript 1 (Neat1) expression in mouse cardiomyocytes. Mechanistically, luciferase reporter analysis indicated that Neat1 could decrease the transcription of miR-140-5p to positively regulate histone deacetylase 4 (HDAC4) expression. Notably, overexpression of miR-140-5p or silencing of HDAC4 rescued Neat1-induced cardiomyocyte apoptosis. DCM was induced in male C57BL/6 mice by intraperitoneal injection with streptozotocin (STZ) combined with a high-fat/high-sugar diet. Further in vivo experiments identified that Catalpol alleviated myocardial damage by regulating Neat1/miR-140-5p/HDAC4 axis in DCM mice. Thus, our results demonstrated that Catalpol could exert cardioprotective effect against DCM via Neat1/miR-140-5p/HDAC4 pathway.

Keywords: Cardiomyocyte apoptosis; Catalpol; Diabetic cardiomyopathy; HDAC4; Neat1.

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Cardiotonic Agents / pharmacology*
  • Cardiotonic Agents / therapeutic use
  • Diabetic Cardiomyopathies / drug therapy*
  • Histone Deacetylases / metabolism*
  • Iridoid Glucosides / pharmacology*
  • Iridoid Glucosides / therapeutic use
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Myocytes, Cardiac / drug effects*
  • RNA, Long Noncoding / metabolism*

Substances

  • Cardiotonic Agents
  • Iridoid Glucosides
  • NEAT1 long non-coding RNA, mouse
  • RNA, Long Noncoding
  • catalpol
  • Hdac5 protein, mouse
  • Histone Deacetylases